Juan Ignacio Esteban

7.7k total citations · 1 hit paper
109 papers, 4.8k citations indexed

About

Juan Ignacio Esteban is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Juan Ignacio Esteban has authored 109 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Hepatology, 76 papers in Epidemiology and 19 papers in Infectious Diseases. Recurrent topics in Juan Ignacio Esteban's work include Hepatitis C virus research (95 papers), Hepatitis B Virus Studies (67 papers) and Liver Disease Diagnosis and Treatment (41 papers). Juan Ignacio Esteban is often cited by papers focused on Hepatitis C virus research (95 papers), Hepatitis B Virus Studies (67 papers) and Liver Disease Diagnosis and Treatment (41 papers). Juan Ignacio Esteban collaborates with scholars based in Spain, United States and Germany. Juan Ignacio Esteban's co-authors include Josep Quer, Rafael Esteban, Sílvia Sauleda, Jordi Gómez, Joan Genescà, J. Guardia, Jaime Guardia, Marı́a Martell, Amy J. Weiner and Beatriz Cabot and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Bioinformatics.

In The Last Decade

Juan Ignacio Esteban

108 papers receiving 4.6k citations

Hit Papers

Hepatitis C virus (HCV) c... 1992 2026 2003 2014 1992 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juan Ignacio Esteban Spain 36 3.8k 3.3k 838 513 355 109 4.8k
Julie Sheldon United Kingdom 39 1.3k 0.3× 2.7k 0.8× 1.6k 2.0× 511 1.0× 348 1.0× 110 4.9k
Etsuro Orito Japan 44 5.3k 1.4× 5.2k 1.6× 669 0.8× 473 0.9× 127 0.4× 137 6.4k
Sergei Viazov Germany 30 1.9k 0.5× 1.9k 0.6× 673 0.8× 268 0.5× 131 0.4× 76 2.8k
J W Shih United States 25 3.3k 0.9× 3.6k 1.1× 558 0.7× 401 0.8× 114 0.3× 40 4.6k
Valérie Thiers France 37 3.7k 1.0× 3.6k 1.1× 517 0.6× 334 0.7× 170 0.5× 91 4.6k
Fumio Tsuda Japan 29 4.3k 1.1× 4.2k 1.3× 1.1k 1.3× 258 0.5× 274 0.8× 52 5.6k
Leslie H. Tobler United States 37 2.8k 0.8× 3.0k 0.9× 1.6k 1.9× 226 0.4× 129 0.4× 74 5.2k
Sílvia Sauleda Spain 27 1.9k 0.5× 2.0k 0.6× 593 0.7× 499 1.0× 120 0.3× 83 3.7k
Qui‐Lim Choo United States 16 6.5k 1.7× 5.5k 1.7× 991 1.2× 993 1.9× 196 0.6× 22 7.6k
P.N. Lelie Netherlands 31 2.8k 0.7× 2.8k 0.8× 700 0.8× 273 0.5× 76 0.2× 88 3.7k

Countries citing papers authored by Juan Ignacio Esteban

Since Specialization
Citations

This map shows the geographic impact of Juan Ignacio Esteban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Ignacio Esteban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Ignacio Esteban more than expected).

Fields of papers citing papers by Juan Ignacio Esteban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Ignacio Esteban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Ignacio Esteban. The network helps show where Juan Ignacio Esteban may publish in the future.

Co-authorship network of co-authors of Juan Ignacio Esteban

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Ignacio Esteban. A scholar is included among the top collaborators of Juan Ignacio Esteban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Ignacio Esteban. Juan Ignacio Esteban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gregori, Josep, Damir García‐Cehic, Carolina Campos, et al.. (2024). In-Host Flat-like Quasispecies: Characterization Methods and Clinical Implications. Microorganisms. 12(5). 1011–1011. 3 indexed citations
2.
Gregori, Josep, Damir García‐Cehic, Mar Riveiro‐Barciela, et al.. (2023). In-Host HEV Quasispecies Evolution Shows the Limits of Mutagenic Antiviral Treatments. International Journal of Molecular Sciences. 24(24). 17185–17185. 3 indexed citations
3.
Rodríguez‐Frias, Francisco, Itziar Ubillos, Ariadna Rando‐Segura, et al.. (2022). Prevalence of Hepatitis C Virus Infection, Genotypes and Subtypes in Migrants from Pakistan in Barcelona, Spain. Infection and Drug Resistance. Volume 15. 4637–4644. 1 indexed citations
4.
Gregori, Josep, Carolina Campos, Damir García‐Cehic, et al.. (2022). Quasispecies Fitness Partition to Characterize the Molecular Status of a Viral Population. Negative Effect of Early Ribavirin Discontinuation in a Chronically Infected HEV Patient. International Journal of Molecular Sciences. 23(23). 14654–14654. 4 indexed citations
5.
García‐Cehic, Damir, Ariadna Rando‐Segura, Francisco Rodríguez‐Frias, et al.. (2021). Resistance‐associated substitutions after sofosbuvir/velpatasvir/voxilaprevir triple therapy failure. Journal of Viral Hepatitis. 28(9). 1319–1324. 6 indexed citations
6.
Costafreda, María Isabel, María Eugenia Soria, Francisco Rodríguez‐Frias, et al.. (2021). Partial restoration of immune response in Hepatitis C patients after viral clearance by direct-acting antiviral therapy. PLoS ONE. 16(7). e0254243–e0254243. 12 indexed citations
7.
Andrés, Cristina, Damir García‐Cehic, Josep Gregori, et al.. (2020). Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients. Emerging Microbes & Infections. 9(1). 1900–1911. 46 indexed citations
8.
García‐Cehic, Damir, Josep Gregori, Francisco Rodríguez‐Frias, et al.. (2019). <p>Whole-genome characterization and resistance-associated substitutions in a new HCV genotype 1 subtype</p>. Infection and Drug Resistance. Volume 12. 947–955. 4 indexed citations
9.
Amer, Fatma, Damir García‐Cehic, Josep Gregori, et al.. (2019). <p>Deep-sequencing study of HCV G4a resistance-associated substitutions in Egyptian patients failing DAA treatment</p>. Infection and Drug Resistance. Volume 12. 2799–2807. 4 indexed citations
10.
Pons, Mònica, Sergio Rodríguez‐Tajes, Juan Ignacio Esteban, et al.. (2019). Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals. Journal of Hepatology. 72(3). 472–480. 121 indexed citations
11.
Perales, Celia, Qian Chen, María Eugenia Soria, et al.. (2018). Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant. Infection and Drug Resistance. Volume 11. 2207–2210. 18 indexed citations
12.
Gregori, Josep, María Eugenia Soria, Isabel Gallego, et al.. (2018). Rare haplotype load as marker for lethal mutagenesis. PLoS ONE. 13(10). e0204877–e0204877. 9 indexed citations
13.
Soria, María Eugenia, Josep Gregori, Qian Chen, et al.. (2018). Pipeline for specific subtype amplification and drug resistance detection in hepatitis C virus. BMC Infectious Diseases. 18(1). 446–446. 20 indexed citations
14.
Martínez‐Rebollar, Maria, Josep Gregori, Josep Quer, et al.. (2017). Phylogenetic analysis of an epidemic outbreak of acute hepatitis C in HIV-infected patients by ultra-deep pyrosequencing. Journal of Clinical Virology. 92. 42–47. 13 indexed citations
15.
Esteban, Juan Ignacio, Josef van Helden, Philippe Bürgisser, et al.. (2013). Multicenter evaluation of the elecsys® anti‐HCV II assay for the diagnosis of hepatitis C virus infection. Journal of Medical Virology. 85(8). 1362–1368. 18 indexed citations
16.
Marco, A, Juan Ignacio Esteban, Mercè Roget, et al.. (2013). Hepatitis C virus reinfection among prisoners with sustained virological response after treatment for chronic hepatitis C. Journal of Hepatology. 59(1). 45–51. 58 indexed citations
17.
Ortega‐Prieto, Ana Maria, Julie Sheldon, Ana Grande-Pérez, et al.. (2013). Extinction of Hepatitis C Virus by Ribavirin in Hepatoma Cells Involves Lethal Mutagenesis. PLoS ONE. 8(8). e71039–e71039. 48 indexed citations
18.
Rodríguez‐Frias, Francisco, David Tabernero, Josep Quer, et al.. (2012). Ultra-Deep Pyrosequencing Detects Conserved Genomic Sites and Quantifies Linkage of Drug-Resistant Amino Acid Changes in the Hepatitis B Virus Genome. PLoS ONE. 7(5). e37874–e37874. 41 indexed citations
19.
García‐Samaniego, Javier, Vincent Soriano, José M. Miró, et al.. (2002). Management of chronic viral hepatitis in HIV-infected patients: Spanish Consensus Conference. HIV Clinical Trials. 3(2). 99–114. 22 indexed citations
20.
Genescà, Joan, Juan Ignacio Esteban, Josep Quer, et al.. (1993). Hepatitis C virus markers in patients with acute post-transfusion hepatitis treated with interferon alfa-2b.. Gut. 34(2 Suppl). S62–S63. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026